News

Irish AR startup positions itself to compete in growing €13.5bn sector with €600k seed round

UtilityAR, an enterprise software company offering Augmented Reality (AR) integration solutions to businesses, has announced a seed round of €600k as the company positions itself to compete in the rapidly growing AR industry currently worth €13.6bn annually.

HBAN passes €100M angel investment milestone across island of Ireland

HBAN today celebrates more than €100M invested in start-ups on the island of Ireland.

HBAN’s MedTech Syndicate led initial €1.2M investment in Bluedrop Medical

HBAN announces that Bluedrop Medical, a Galway based Medical device start up, has secured €3.7M in funding to help manage one of the most devastating complications of diabetes – the diabetic foot. An initial seed investment of €1.2M was led by HBAN’s MedTech Syndicate - which itself invested €340K in the seed round. Enterprise Ireland and the Western Development Commission also invested in the funding round along with other members of the investment community.  A €2.5M grant was awarded through the European Innovation Council.

Deciphex Finalise €2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs

Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.

Signum Surgical Receives €3.6 Million in Grant Funding to Support Launch of Therapy for Patients with a Common Colorectal Disease

Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, today announced the company has secured €3.6 million ($4 million) through two grant funding awards. The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Funds from these grants will support regulatory and clinical programs leading to the commercialization of the company’s BioHealxTM device, which is designed to treat anal fistula, a painful colorectal condition that affects one in 5,000 people worldwide.

CroíValve raises €3.2M in oversubscribed funding round

CroíValve, a medtech start-up providing a safe and effective treatment for tricuspid regurgitation, today announces that it has secured €3.2 million in an oversubscribed seed financing round. The round was led by the HBAN (Halo Business Angel Network) MedTech and Irrus Syndicates, alongside Atlantic Bridge University Fund, Enterprise Ireland, SOSV and a group of cardiologists who see the treatment’s transformative potential. The funding will support the continued development of CroíValve’s innovative technology.

Hexafly secures another €1.1M in funding

HBAN announces agritech company, Hexafly have secured a total of €2.2m after closing a recent round of €1.1m. 

Talking to an Angel

Angel investment is growing in popularity as a source of early-stage funding for start-ups. Better Business looks at the relationship between company and investor and uncovers how best to strike a deal.

HBAN’s MedTech Syndicate leads €1.1M investment in Ostoform

HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTrade Ireland, today announces that its MedTech Syndicate has led a €1.1 million Series A funding round in medical device start-up, Ostoform. HBAN Angels contributed €280,000, with venture capital investor, SOSV, Enterprise Ireland, and other angel investors making up the rest of the funding round.

The Bank of Ireland Kernel Capital Fund Invest €1.7M in Dublin Based Sytorus

The Bank of Ireland Kernel Capital Early & Growth Stage Funds have invested €1.7M in Sytorus Ltd, this is in addition to simultaneous investment from Enterprise Ireland and private investors.  Established by Dr. John Ghent (CEO), Mike Morrissey (COO) and Hugh Jones (CPO) in 2013, Sytorus’s flagship software ‘PrivacyEngine’ is a dynamic GDPR and Data Protection SAAS product. It provides end-to-end data protection solutions to corporate clients.  The Company, with over 50 staff, is scaling rapidly and today has over 300 hundred fee paying corporate clients worldwide. Sytorus has opened offices in Stockholm and London, and this latest investment will facilitate a new office to open in Frankfurt.
Page 1 of 4